Business Description
Founded in Melbourne in 2021, Cleo Diagnostics Ltd develops blood tests that can identify ovarian cancer without the need for invasive procedures. Its main product, CleoDX, analyzes five biological markers in a patient's blood sample to help doctors assess the likelihood of cancer before recommending surgery. The company also works to protect its discoveries through patents and intellectual property rights.
